Medexus Pharmaceuticals, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA58410Q2036
CAD
2.85
0.95 (50.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1112615,
    "name": "Medexus Pharmaceuticals, Inc.",
    "stock_name": "Medexus Pharmaceuticals, Inc.",
    "full_name": "Medexus Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/medexus-pharmaceuticals-inc",
    "exchange": 1,
    "exchangecode": "TSE",
    "country_id": 1,
    "currency": "CAD",
    "cmp": "2.85",
    "chg": 0.95,
    "chgp": "50.0%",
    "dir": 1,
    "prev_price": "1.90",
    "mcapval": "93.69",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P/TSX 60",
    "isin": "CA58410Q2036",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "83.48 k",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medexus-pharmaceuticals-inc-1112615-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medexus Pharmaceuticals Adjusts Financial Metrics Amid Mixed Technical Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medexus-pharmaceuticals-downgraded-to-strong-sell-amid-mixed-technical-and-valuation-scores-3768379",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MedexusPharmace_mojoScore_3768379.png",
        "date": "2025-12-24 15:45:56",
        "description": "Medexus Pharmaceuticals, Inc. has recently experienced an evaluation adjustment reflecting changes in its financial metrics. The stock's overall assessment has been revised, with mixed technical indicators suggesting varying trends. Valuation metrics have shifted from very expensive to fair, providing a clearer view of the company's financial standing."
      }
    ],
    "total": 2,
    "sid": "1112615",
    "stock_news_url": "https://www.marketsmojo.com/news/medexus-pharmaceuticals-inc-1112615"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available